AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06112366 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Surgery of impacted mandibular wisdom teeth (the other side)
Description: All surgical procedures were performed by the same surgeon using the standard surgical technique described below. The anesthetic used was 4% articaine with 1:100,000 adrenaline. In all patients, a sulcus incision was made in the lower second molar and an envelope incision in the third molar region, the mucoperiosteal flap was removed, and extraction was performed with a bone elevator and a third molar elevator. If necessary, the impacted molar was incised with a high-speed dental handpiece and a fissure bur. The wound was irrigated with copious amounts of saline, and the wound edges were carefully sutured with simple 4.0 silk braided non-absorbable sutures.
Study NCT05849649 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: BumptUp
Description: The app contains a number of evidence-based, expertly designed features to help women with healthier lifestyle habits during and after pregnancy.
Study NCT05849649 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Educational Brochure
Description: An evidence-based brochure on physical activity
Study NCT04939805 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Selective CRP apheresis using the PentraSorb®-CRP system
Description: Selective CRP apheresis as an adjunct to standard of care. Apheresis using the PentraSorb®-CRP system will be performed at day 1, 2 and 3 after PCI.
Study NCT05620849 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Online program
Description: The online program is 4 weeks and focused on topics such as alcohol and sexual health
Study NCT05304078 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Telehealth Assessment and Skill-Building Kit (TASK III) Group
Description: The TASK III group will receive a TASK III Resource Guide (mailed hard copy, USB drive, eBook, and Website access) and 8 weekly calls from a nurse, with a booster call a month later (telephone, videoconferencing, or FaceTime). The TASK III nurse will train caregivers how to assess their needs and concerns, and how to use the TASK III Resource Guide containing content and skill-building tip sheets to address their needs and concerns. Caregivers will also receive an American Heart Association brochure about family caregiving, as well as information, support, and referral to community resources.
Study NCT05304078 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Information Support and Referral (ISR) Group
Description: The ISR group will receive an American Heart Association brochure about family caregiving and 8 weekly calls from a nurse, with a booster call a month later (telephone, videoconferencing, or FaceTime). The ISR nurse will provide information, support, and referral to community resources.
Study NCT05926687 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Social Communication
Description: Intervention: Social Communication Who: Parent \& Child \& Therapist Frequency: 1-hour twice/week
Study NCT05926687 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Disruptive Behavior
Description: Intervention: Disruptive Behavior Who: Parent \& Therapist only Frequency: 1-hour once/week
Study NCT05926687 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Social Communication + Reduce Frequency
Description: Intervention: Social Communication Who: Parent \& Child \& Therapist Frequency: 1-hour once/week
Study NCT05926687 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Social Communication + Add Tools
Description: Intervention: Social Communication Who: Parent \& Child \& Therapist Frequency: 1-hour twice/week
Study NCT05926687 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Disruptive Behavior + Reduce Frequency
Description: Intervention: Disruptive Behavior Who: Parent \& Therapist only Frequency: 1-hour every other week
Study NCT05926687 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Disruptive Behavior + Add Tools
Description: Intervention: Disruptive Behavior Who: Parent \& Therapist only Frequency: 1-hour once/week
Study NCT05588622 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Meru Health Program
Description: The Meru Health Program is a 12-week, evidence-based, smartphone-delivered, therapist-supported digital mental health intervention with as-needed psychiatrist oversight. Enrolled participants work through the program with a cohort of peers similarly affected by depression, with whom they can engage in confidential, anonymous, voluntary group chats overseen by a licensed clinical therapist. The MHP incorporates a continuous care model including daily interaction with a dedicated clinician, several evidence-based treatment components such as cognitive behavioral therapy (CBT), behavioral activation therapy, and mindfulness meditation (MM), as well as promising newer types of depression treatments such as HRVB, nutritional psychiatry, and sleep training. Practices are introduced to weekly topics via video lessons that are reinforced via CBT practices, meditations, and biofeedback sessions and therapist messaging.
Study NCT05714176 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ferric Pyrophosphate Liposomal
Description: 30 pediatric patients who will receive oral liposomal iron (Novoferr) 30 mg/day for 12 weeks.
Study NCT05714176 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lactoferrin
Description: 30 pediatric patients who will receive oral iron supported Lactoferrin (Provan) 100 mg/day for 12 weeks.
Study NCT05714176 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Iron Dextran Injection
Description: 30 pediatric patients who will receive IV iron dextran 50 mg /3 times weekly for 12 weeks.
Study NCT06088017 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CKD-391(2)
Description: QD, PO
Study NCT06088017 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CKD-331, D337
Description: QD, PO
Study NCT05617274 — intervention group
Intervention type: PROCEDURE
Intervention: Sectioning of the full arch mandibular fixed prosthesis
Description: The one unit full arch fixed prosthesis is sectioned at the midline into two pieces
Study NCT05009810 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: astaxanthin 4 mg
Description: They will take astaxanthin 4 mg 1 capsule once daily for 2 months.
Study NCT05009810 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: astaxanthin 6 mg
Description: They will take astaxanthin 6 mg 1 capsule once daily for 2 months.
Study NCT05009810 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: They will take placebo 1 capsule once daily for 2 months.
Study NCT01274403 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Melphalan, Prednisone and Thalidomide
Study NCT01274403 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Melphalan, Prednisone and Thalidomide
Study NCT04010266 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: RelieVRx headset
Description: RelieVRx is a virtual reality therapy intended as adjunctive treatment for acute surgical pain
Study NCT04010266 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: multi-modality pain management
Description: combination of medications may be used such as a local anesthesia, ibuprofen, acetaminophen, gabapentin, ketamine, lidocaine, and opioids
Study NCT04010266 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: multi-modality pain management
Description: combination of medications may be used such as a local anesthesia, ibuprofen, acetaminophen, gabapentin, ketamine, lidocaine, and opioids
Study NCT04752501 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Psychologically Informed Education
Description: This arm will provide an education intervention which will attempt to address maladaptive psychological behaviors in adolescents with knee pain
Study NCT04752501 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Biomedical Education (Control)
Description: This arm will provide education of basic knee anatomy, lower extremity mechanics, and simple exercises and will not address maladaptive psychological behaviors
Study NCT05539807 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindful Eating Conscious Living
Description: MECL is a 8 week mindfulness-based group intervention. Each session is of 2.5-3 hours duration. During the sessions, theories about eating-related difficulties in general are presented, participants are guided in mindfulness practices and participants who want to share their experiences in the group can do so. Topics include: (1) What is mindfulness, why and how can we use mindfulness in relation to eating (2) slowing down, taking breaks and noticing different types of hunger (e.g. physical hunger and the hunger for comfort - heart hunger) (3) working with satiety and satisfaction (4) becoming aware of patterns associated with one's eating behaviors, (5) awareness of feelings and bodily sensations (6) Food and mood (7) craving, and finally (8) working with heart hunger and emotional eating. Six to 10 participants participated in each group.
Study NCT05311189 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HLX10, Trastuzumab and Chemotherapy
Description: HLX10 4.5mg/kg, IV, q3weeks, Day 1 trastuzumab 6mg/kg (8mg loading dose), IV, q3weeks, Day 1 S1 40mg/m2, PO, BID, Day 1-14 oxaliplatin 100mg/m2, IV, q3weeks, Day 1 docetaxel 40mg/m2, IV, q3weeks, Day 1
Study NCT05589077 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Education on Female Athlete Nutritional Concerns
Description: Visual and audio information presented within the Qualtrics system will cover topics on the Female Athlete Triad, Relative Energy Deficiency in Sport, and eating disorders.
Study NCT04452825 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cancer and Aging: Reflections for Elders (CARE) Intervention
Description: For full participants (not training case participants) five sessions (45-60 minutes each) will be delivered over an 8-week period (+4 weeks). Following these sessions, four brief booster sessions (20-30 minutes each) will be delivered at a rate of approximately one per month to extend the interventions to 6 months (+3 months).
Study NCT04452825 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Social Work and Supportive Counseling (SWSC) Intervention
Description: The SWSC will include a social work assessment and follow-up augmented with additional components of supportive psychotherapy that have been shown to be an effective form of treatment for patients with cancer. For full participants (not training case participants) five sessions (45-60 minutes each) will be delivered over an 8-week period (+4 weeks). Following these sessions, four brief booster sessions (20-30 minutes each) will be delivered at a rate of approximately one per month to extend the interventions to 6 months (+3 months). Training case participants will follow a slightly condensed schedule.
Study NCT05215444 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: some prognostic factors
Description: cortisol level, renin, troponin I, MDA ,catalase, super oxide dismutase, liver functions, kidney functions, arterial blood gases, sodium level, potassium level. white blood cells count
Study NCT05842148 — intervention group
Intervention type: OTHER
Intervention: Study and recording of post-surgical clinical and pathological data of patients diagnosed with breast cancer undergoing unilateral or bilateral conservative oncoplastic surgery.
Description: Control and review of pathological parameters (oncological radicality resection volume, locoregional extension / TNM / multifocality and tumor biological profile).
Study NCT05842148 — intervention group
Intervention type: OTHER
Intervention: Study and recording of any associated post-surgical complications (of patients diagnosed with breast cancer undergoing unilateral or bilateral conservative oncoplastic surgery.
Description: Control and review of post-surgical complications (dehiscence, liponecrosis, infection, seroma, hematoma, fibrosis, scar hypertrophy).
Study NCT04657718 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: KODEX-EPD system
Description: Cardiac pacing leads implantation for PM, ICD, CRT, HBP and LBBP
Study NCT05842148 — intervention group
Intervention type: OTHER
Intervention: Study and recording of aesthetic and functional post-surgical results related to the quality of life, as data perceived by the surgeon (technical analysis), and by the patient.
Description: Control and review of technical analysis by the surgeon, and of psychosocial well-being, physical discomfort, adverse effects of radiotherapy by the patient collected through the administration of a questionnaire.
Study NCT06524856 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Lung Master (Pulmonary Exerciser)
Description: During the one-month using the Lung Master at their house, the participant will be using it at least one time every day, either in the morning or in the evening before going to sleep. During the session, the participants will sit upright and try to prolong the inhalation and exhalation breaths through the Lung Master device for at least three seconds. For each session, the participants will try to concentrate on 35-50 breaths in and breaths out which is about 2-5 minutes. Every session can involve using the Pulmonary Exerciser for a minimum of 5 minutes and a maximum of 20 minutes. After each session, participants will be asked to note how long they have used the device and when they have used it. Information from each session will be recorded on the Participant Device Log that will be provided.
Study NCT06205251 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: POWERbreathe Plus IMT
Description: Inspiratory muscle training will be performed using the POWERbreathe Plus IMT (POWERbreathe International Ltd., Warwickshire, UK), a commercially available inspiratory pressure threshold device. In this type of training, airflow is occluded until the generated inspiratory pressure reaches the predetermined threshold, which can be set at increments of 8 cm H2O.~During the first week of training, the target intensity will be set at 50% of baseline maximal inspiratory pressure (MIP.) During the second week, the target intensity will be set at 60% of baseline MIP. Beginning at the third week and for the remainder of the training program, the target intensity will be set at 75% of the participant's baseline MIP. The target volume will be 5 sets of 6 breaths per day (total of 30 breaths per day), separated by 1-minute rest breaks between sets. The frequency of training will be 5 days per week, for a duration of 6 weeks.
Study NCT05303428 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Neuromodulation with low-intensity focused ultrasound
Description: application of LIFU to induce temporary neuromodulation, effects tested with resting state and task based fMRI scanning.
Study NCT05950698 — intervention group
Intervention type: DEVICE
Intervention: Holter Faros 360° EKG (Bittium Corporation)
Description: Patients will lie down on the examination table, a five-lead ECG will be attached to their chest, and they should rest for 5 minutes before starting the ECG recording. ECG data will be collected for a 15-minute period Heart Rate Variability (HRV) recording will be performed between 09:00 and 12:00 in a fixed examination room to minimize environmental factors and diurnal fluctuations in autonomic nervous system functioning.
Study NCT05950698 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Beck Depression Inventory (BDI)
Description: The BDI assesses the depression severity. It will be administered before bariatric surgery at time T0 and 3-6-12-24 months after bariatric surgery (T1-T2-T3-T4).
Study NCT05950698 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Hospital Anxiety and Depression Scales - HADS
Description: The HADS assesses the anxiety and depression symptoms. It will be administered before bariatric surgery at time T0 and 3-6-12-24 months after bariatric surgery (T1-T2-T3-T4).
Study NCT05623319 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab/Olaparib
Description: Patients will receive pembrolizumab 200 mg 1q21 and chemotherapy -platinum compound (cisplatin 75 mg/m2 or carboplatin area under the curve of 5 mg per milliliter per minute) 1q21 plus etoposide 100 mg/m2 1-3q21- for 4 cycles (Induction Phase). In case of responsive or stable disease, patients will receive pembrolizumab 200 mg 1q21 plus olaparib 300 mg twice daily until progression (Maintenance Phase) or up to a maximum of 35 cycles.
Study NCT05950698 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Three Factor Eating Questionnaire-R21 - TFEQ-R21
Description: The TFEQ-R21assesses the quality of eating behavior. It will be administered before bariatric surgery at time T0 and 3-6-12-24 months after bariatric surgery (T1-T2-T3-T4).
Study NCT05950698 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: hort-Form Health Survey-36 itens - SF-36
Description: he TFEQ-R21assesses the quality of life Divided into different areas (functional capacity, general health status, pain, vitality, social aspects, emotional aspects, and mental health). It will be administered before bariatric surgery at time T0 and 3-6-12-24 months after bariatric surgery (T1-T2-T3-T4).
Study NCT06245252 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: passive stretching for group A
Description: A description of stretch is performed 3 times per week for 12 weeks. The stretches included (in the order they were applied): Seated knee flexor (bilateral); Seated knee flexor-hip adductor (bilateral); Seated shoulder lateral flexor (bilateral); Supine hip flexor- knee extensor (unilateral). Seated hip external rotators, extensor (unilateral); Seated shoulder extensors, adductors, retractors (unilateral). Supine knee flexor-plantar flexor (unilateral); Prone hip flexor (unilateral); Seated shoulder flexors, depressors (bilateral); Seated shoulder and elbow flexors (unilateral).
Study NCT06245252 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: electrical stimulation for group b
Description: reated by 30 minutes electrical stimulation three times per week for 12 weeks
Study NCT05499533 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: implant site preparation
Description: a hole were created in the edentulous ridge area before implant placement
Study NCT05499533 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: implant site preparation
Description: a hole were created in the edentulous ridge area before implant placement
Study NCT06574516 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ibuprofen 200 mg
Description: Ibuprofen every 8 hours for three days post operatively
Study NCT04640948 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: High flow nasal therapy
Description: Controlled oxygen administration using at least 20 L/min of flow rate and titrated up as tolerated. Titration of supplemental oxygen to an arterial saturation between 88 - 92%.
Study NCT06574516 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: paracetamol
Description: Paracetamol PRN for three days
Study NCT06574516 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: paracetamol
Description: Paracetamol PRN for three days
Study NCT05795985 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: calprotectin levels
Description: dosage of calprotectin levels in patients with abdominal pain
Study NCT06348667 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Specific ankle stability exercises
Description: Exercise program specifically designed to address ankle dorsiflexion and mediolateral displacement of the center of pressure, using the described device (BB). Done twice a week for 5 weeks.
Study NCT06497816 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: No intervention
Study NCT06348667 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional physiotherapy exercises program
Description: Conventional exercise program performed in the center twice a week, of which all participants are part.
Study NCT05421559 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: thyroidectomy
Description: removal of the diseased thyroid gland by conventional method vs transection method of sternothryroid muscle
Study NCT05613829 — intervention group
Intervention type: OTHER
Intervention: Burn surgery
Description: Patients underwent burn surgery
Study NCT05913024 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Enterovirus Type 71 Vaccine
Description: Participants received two doses of the vaccine, 28 days apart
Study NCT04640948 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Low flow oxygen
Description: Controlled oxygen administration using (venturi mask or nasal cannulae) titrated to an arterial saturation between 88 - 92% as the initial oxygen administration method with a flow rate of \<20 L/min.
Study NCT05913024 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Enterovirus Type 71 Vaccine
Description: Participants received two doses of the vaccine, 28 days apart
Study NCT05492864 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: extrusion of the anterior teeth
Description: sectional leveling and alignment of the teeth, then using of the extrusion arch as an overlay wire to treat the open bite
Study NCT05233956 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: LNG IUS
Description: Avibela®: Levonorgestrel intrauterine system (LNG IUS) containing 52mg of LNG, released in the uterine cavity at approximately 19mcg per day.
Study NCT05233956 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: COCs
Description: FemiplanTM: Combined oral contraceptives in a 21/7 pill package (21 pills of 0.15 mg of LNG and 30 mcg of EE followed by 7 pills containing 75 mg of ferrous fumarate).
Study NCT05732740 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Empower@Home:Connected
Description: Cognitive behavioral therapy
Study NCT06291831 — intervention group
Intervention type: DRUG
Intervention: nirmatrelvir, ritonavir
Description: Patients receiving Nirmatrelvir; Ritonavir (PAXLOVID)